<?xml version="1.0" encoding="UTF-8"?>
<doi_batch version="4.3.0" xmlns="http://www.crossref.org/doi_resources_schema/4.3.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.crossref.org/doi_resources_schema/4.3.0 http://www.crossref.org/schema/deposit/doi_resources4.3.0.xsd">
<head>
<doi_batch_id>062bfa2d-bd54-4d20-80f2-4061a7a2f682</doi_batch_id>
<depositor>
<name>beie</name>
<email_address>director@blueeyesintelligence.org</email_address>
</depositor>
</head>
<body>
<doi_citations>
<doi>10.35940/ijitee.D8497.0210421</doi>
<citation_list><citation key="ref0"><doi>10.2174/187152011796011073</doi><unstructured_citation>1. H. Pan, X. Fu, andW. Huang, &quot;Molecular mechanisms of liver cancer,&quot;Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents), vol. 11, no. 6, pp. 493-499,2011..</unstructured_citation></citation><citation key="ref1"><doi>10.1002/ijc.29210</doi><unstructured_citation>2. J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, D. M. Parkin, D. Forman, and F. Bray, &quot;Cancer incidence and mortality worldwide: sources, methods and major patterns in globocan 2012,&quot; International journal of cancer, vol. 136, no. 5, 2015.</unstructured_citation></citation><citation key="ref2"><doi>10.1016/S0140-6736(12)60919-2</doi><unstructured_citation>3. I. Soerjomataram, J. Lortet-Tieulent, D. M. Parkin, J. Ferlay,C. Mathers, D. Forman, and F. Bray, &quot;Global burden of cancer in 2008: a systematic analysis of disabilityadjusted life-years in 12 world regions,&quot; The Lancet, vol. 380, no. 9856, pp. 1840-1850, 2012.</unstructured_citation></citation><citation key="ref3"><doi>10.1200/JCO.2008.20.7753</doi><unstructured_citation>4. S. F. Altekruse, K. A. McGlynn, and M. E. Reichman, &quot;Hepatocellular carcinoma incidence, mortality, and survival trends in the united states from 1975 to 2005,&quot; Journal of clinical oncology, vol. 27, no. 9, pp. 1485-1491, 2009.</unstructured_citation></citation><citation key="ref4"><doi>10.1186/1471-2164-16-S3-S4</doi><unstructured_citation>5. S.-P. Deng, L. Zhu, and D.-S. Huang, &quot;Mining the bladder cancerassociated genes by an integrated strategy for the construction and analysis of differential co-expression networks,&quot; BMC genomics, vol. 16, no. 3, p. S4, 2015.</unstructured_citation></citation><citation key="ref5"><doi>10.1109/TCBB.2015.2476790</doi><unstructured_citation>6. &quot;Predicting hub genes associated with cervical cancer through gene co-expression networks,&quot; IEEE/ACM Transactions on Computational Biology and Bioinformatics (TCBB), vol. 13, no. 1, pp. 27-35, 2016.</unstructured_citation></citation><citation key="ref6"><doi>10.1109/BIBM.2016.7822743</doi><unstructured_citation>7. S.-P. Deng, D. Lin, V. D. Calhoun, and Y.-P. Wang, &quot;Schizophrenia genes discovery by mining the minimum spanning trees from multi-dimensional imaging genomic data integration,&quot; in Bioinformatics and Biomedicine (BIBM), 2016 IEEE International Conference on. IEEE, 2016, pp. 1493-1500.</unstructured_citation></citation><citation key="ref7"><doi>10.1103/PhysRevE.71.016116</doi><unstructured_citation>8. A. E. Motter, C. Zhou, and J. Kurths, &quot;Network synchronization, diffusion, and the paradox of heterogeneity,&quot; Physical Review E, vol. 71, no. 1, p. 016116, 2005.</unstructured_citation></citation><citation key="ref8"><doi>10.2174/1389203715666140724084019</doi><unstructured_citation>9. D.-S. Huang, L. Zhang, K. Han, S. Deng, K. Yang, and H. Zhang,&quot;Prediction of proteinprotein interactions based on proteinprotein correlation using least squares regression,&quot; Current Protein and Peptide Science, vol. 15, no. 6, pp. 553-560, 2014.</unstructured_citation></citation><citation key="ref9"><doi>10.1093/nar/gkx356</doi><unstructured_citation>10. J. Wang, S. Vasaikar, Z. Shi, M. Greer, and B. Zhang, &quot;Webgestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit,&quot; NucleicAcids Research, 2017.</unstructured_citation></citation><citation key="ref10"><doi>10.1007/978-1-62703-435-7_20</doi><unstructured_citation>11. C. F. Thorn, T. E. Klein, and R. B. Altman, &quot;Pharmgkb: the pharmacogenomics knowledge base,&quot; Pharmacogenomics: Methods and Protocols, pp. 311-320, 2013.</unstructured_citation></citation><citation key="ref11"><doi>10.1186/1471-2164-13-S8-S20</doi><unstructured_citation>12. J. Jourquin, D. Duncan, Z. Shi, and B. Zhang, &quot;Glad4u: deriving and prioritizing gene lists from pubmed literature,&quot; BMC genomics, vol. 13, no. 8, p. S20, 2012.</unstructured_citation></citation><citation key="ref12"><doi>10.1103/PhysRevE.73.046108</doi><unstructured_citation>13. G. Yan, T. Zhou, B. Hu, Z.-Q. Fu, and B.-H. Wang, &quot;Efficient routing on complex networks,&quot; Physical Review E, vol. 73, no. 4, p. 046108, 2006.</unstructured_citation></citation><citation key="ref13"><doi>10.1103/PhysRevE.65.036104</doi><unstructured_citation>14. R. Pastor-Satorras and A. Vespignani, &quot;Immunization of complex networks,&quot; Physical Review E, vol. 65, no. 3, p. 036104, 2002.</unstructured_citation></citation><citation key="ref14"><doi>10.1016/j.physa.2013.06.059</doi><unstructured_citation>15. C. Gao, D. Wei, Y. Hu, S. Mahadevan, and Y. Deng, &quot;A modified evidential methodology of identifying influential nodes in weighted networks,&quot; Physica A: Statistical Mechanics and its Applications, vol. 392, no. 21, pp. 5490-5500, 2013.</unstructured_citation></citation></citation_list>
</doi_citations>
</body>
</doi_batch>
